Developer docs
API playgroundTry for free, no card

Search company profiles

Win Medica

Full company profile

uuid0026brb

Namestring
Win Medica
Legal namestring
WIN MEDICA A.E.
Websiteurl
winmedica.gr
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Win Medica A.E. is a Greek pharmaceutical company, founded in 2008 and headquartered in Marousi, Athens, that specializes in the in-licensing, registration, and commercialization of innovative pharmaceutical treatments for the Greek and broader international markets. The company operates across 11 therapeutic areas organized around four focus pillars: (1) specialty medicines in oncology, hematology, immunology and urology; (2) chronic care branded generics for hypertension, diabetes, cholesterol and obesity; (3) vaccines and consumer health, including the Seqirus-partnered FLUAD influenza vaccine and Pharmanutra-partnered SiderAL and UltraMag Oro supplements; and (4) advanced manufacturing and R&D, anchored by a new high-potency facility in Tripoli with 500 million tablets/year capacity. Its revenue model is built on prescription pharmaceutical sales and OTC distribution through Greek pharmacies and healthcare providers, supplemented by proprietary sub-brands such as Sofargen (wound care), Valetonina (sleep aid), and Tokovys (smoking cessation), with go-to-market executed via an enterprise field-sales motion targeting HCPs and a dedicated healthcare-professional portal.

Strategically, Win Medica is a subsidiary of the ELPEN Group, participating in a combined 400+ million euro investment program with sister companies DEMO ABEE and FARAN that is creating over 1,500 direct and indirect high-specialization jobs. The firm has grown to 210-220+ professionals serving approximately 650,000 patients annually across 42+ countries, with a portfolio of 87+ registered products. Its competitive position rests on established Greek regulatory and distribution infrastructure, vertically integrated manufacturing now anchored by the Tripoli plant, and a broad alliance network with 14+ multinational pharmaceutical partners, though no revenue, financial performance, or AI/ML capabilities are publicly disclosed.

Short descriptiontext

Greek pharmaceutical company (founded 2008, Athens) that in-licenses, registers, and commercializes innovative treatments across 11 therapeutic areas for Greek patients and 42+ international markets, supported by a new 500 million-tablet Tripoli manufacturing facility and 14+ multinational pharma partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersAthens, Greece
HQ citystring
Athens
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical products, specialty medicines, chronic care treatments, medical devices, pharmaceutical manufacturing
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical product sales
TypeOne Time License
Description

Win Medica develops and delivers treatments across specialty medicines, chronic care, and vaccines & consumer health. They in-license, register, and commercialize innovative treatments from global pharmaceutical partners.

winmedica.gr
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Sofargen
Description

Wound care product line including Sofargen Repair (water-based dressing with hyaluronic acid and silver sulfadiazine), Sofargen Spray (powder for minor wounds), and Sofargen Gel

winmedica.gr
+4 more records
Core offering1 text field

Win Medica is a Greek pharmaceutical company that in-licenses, registers, and commercializes innovative pharmaceutical treatments in partnership with leading global pharmaceutical companies. The company develops, manufactures, and distributes a portfolio of 87+ prescription medicines, OTC products, medical devices, and dietary supplements across 11 therapeutic areas including specialty medicines (oncology, hematology, immunology, urology), chronic care (hypertension, diabetes, cholesterol, obesity), and vaccines/consumer health.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 500 million tablets per year manufacturing capacity
+2 more records
Product overview1 text field

Win Medica is a Greek pharmaceutical company (since 2008) specializing in in-licensing, registration, and commercialization of innovative treatments. The company operates a portfolio of 87+ pharmaceutical products including prescription medications, OTC products, medical devices, and dietary supplements. Their therapeutic focus spans four areas: (1) Specialty medicines in oncology, hematology, immunology, and urology; (2) Chronic care including branded generics for hypertension, diabetes, cholesterol and obesity; (3) Vaccines and consumer health; and (4) Advanced manufacturing via their new Tripoli facility with 500 million tablet capacity. Key branded products include Sofargen® (Repair, Spray, Gel) wound care medical devices, SiderAL® iron supplements (Forte, Folico, Sport, Drops), Valetonina® melatonin/valerian sleep aid, UltraMag® Oro magnesium supplement, Vitrex-Easydrip insulin needles, and On Call glucose meters. The company holds strategic partnerships with multinational pharmaceutical companies including Seqirus, Novartis, Accord, Viatris, Servier, and others to distribute their products in the Greek market.

Product and service10 records
1Sofargen® Repair
CategoryMedical Device - Wound Care
Description

Water-based wound dressing containing hyaluronic acid and silver sulfadiazine for topical treatment of skin lesions including abrasions, cuts, wounds, burns, and superficial wounds.

2Sofargen® Spray
CategoryMedical Device - Wound Care
Description

Medical device in powder form containing kaolin and silver sulfadiazine for treatment of minor skin wounds including cuts, abrasions, and superficial wounds.

3Sofargen® Gel
CategoryMedical Device - Wound Care
Description

Medical device gel with silver sulfadiazine and high water content (>95%) for wound care, maintaining wound moisture and preventing infections.

4Valetonina®
CategoryDietary Supplement - Sleep Aid
Description

Dietary supplement combining melatonin and valerian with innovative dual-release technology for treatment of insomnia and jet lag.

5UltraMag® Oro
CategoryDietary Supplement - Mineral
Description

Magnesium supplement utilizing patented sucrosomal technology for enhanced absorption to treat magnesium deficiency symptoms including insomnia, fatigue, muscle cramps, and headaches.

6Vitrex - Easydrip
CategoryMedical Device - Diabetes Care
Description

High-tech pen-type insulin scalpers and needles from Scandinavia, compatible with most insulin devices and pens on the market. Available in 30G, 31G, and 32G sizes.

7Tokovys®
CategoryPrescription Medication
Description

Smoking cessation treatment containing cytisinicline.

8SiderAL® Sport
CategoryDietary Supplement - Iron
Description

Iron and vitamin B-complex supplement using sucrosomal technology for athletes and those with increased physical or mental demands.

9On Call Extra
CategoryMedical Device - Diabetes Care
Description

Glucose meter for diabetes monitoring.

10On Call Vivid
CategoryMedical Device - Diabetes Care
Description

Glucose meter for diabetes monitoring.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance bringing Seqirus vaccine products to the Greek market, including FLUAD influenza vaccine

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance with Novartis for distribution of pharmaceutical products in Greece

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance with Accord for generic pharmaceutical products

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Pharmanutra for consumer health products including UltraMag Oro and SiderAL products

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance with Adamed for pharmaceutical product distribution

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with Mabxience for biosimilar and pharmaceutical products

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance with Chemo for pharmaceutical product distribution

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with Medis for pharmaceutical products

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance with Sofar for pharmaceutical product distribution

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with Welding for pharmaceutical products

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance with Viatris for generic and specialty pharmaceutical products

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with Servier for pharmaceutical product distribution

13Polpharma
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance with Polpharma for generic pharmaceutical products

winmedica.gr
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with Midas Pharma for pharmaceutical products

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global pharmaceutical company formed from Mylan-Pfizer Upjohn, focused on generics and specialty. Strategic partner of Win Medica (supplying generic and specialty products to the Greek market) and a direct competitor in the broader European branded-generics space.

TypeRegional player
Description

Polish pharmaceutical manufacturer and one of the largest generic producers in Central Europe. Strategic partner of Win Medica and a comparable regional generic-and-specialty player with cross-border distribution reach.

TypeBroad incumbent
Description

European-focused generics and specialty pharma leader with consumer health business. Closely comparable business model combining generics, specialty, and consumer health across European markets with similar product breadth.

TypeBroad incumbent
Description

Global originator pharmaceutical leader with deep Greek market presence. Strategic distribution partner of Win Medica and a broad incumbent whose therapeutic areas (oncology, immunology, chronic care) overlap with Win Medica's portfolio.

TypeDirect peer
Description

Sister company within ELPEN Group focused on pharmaceutical manufacturing and distribution. Co-investor in the €400M+ strategic investment plan with Win Medica, operating in overlapping therapeutic segments.

TypeRegional player
Description

Polish pharmaceutical company with branded generics, specialty, and consumer health operations across Central/Eastern Europe. Strategic partner of Win Medica and comparable in product mix and regional orientation.

TypeRegional player
Description

Slovenian-headquartered generic pharmaceutical manufacturer with strong presence across Central, Eastern, and Southern Europe. Comparable vertically integrated generics + specialty model serving similar regional markets.

TypeDirect peer
Description

Global biosimilars developer and manufacturer. Strategic partner of Win Medica and a comparable in-licensing/partner-driven player bringing biologic products into regional European markets, with overlapping specialty therapeutic focus.

TypeDirect peer
Description

Parent company of Win Medica and the largest Greek pharmaceutical manufacturer. Directly comparable vertically integrated model combining manufacturing, R&D, and domestic commercialization of branded generics and specialty products.

10DEMO ABEE
TypeDirect peer
Description

Sister company under ELPEN Group and one of Greece's largest injectable pharmaceutical manufacturers. Joint strategic investor in the Tripoli facility and directly comparable in product categories (sterile injectables, hospital specialty).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Win Medica

Pharmaceuticalswinmedica.gr

Greek pharmaceutical company (founded 2008, Athens) that in-licenses, registers, and commercializes innovative treatments across 11 therapeutic areas for Greek patients and 42+ international markets, supported by a new 500 million-tablet Tripoli manufacturing facility and 14+ multinational pharma partnerships.

What Win Medica does

Win Medica A.E. is a Greek pharmaceutical company, founded in 2008 and headquartered in Marousi, Athens, that specializes in the in-licensing, registration, and commercialization of innovative pharmaceutical treatments for the Greek and broader international markets. The company operates across 11 therapeutic areas organized around four focus pillars: (1) specialty medicines in oncology, hematology, immunology and urology; (2) chronic care branded generics for hypertension, diabetes, cholesterol and obesity; (3) vaccines and consumer health, including the Seqirus-partnered FLUAD influenza vaccine and Pharmanutra-partnered SiderAL and UltraMag Oro supplements; and (4) advanced manufacturing and R&D, anchored by a new high-potency facility in Tripoli with 500 million tablets/year capacity. Its revenue model is built on prescription pharmaceutical sales and OTC distribution through Greek pharmacies and healthcare providers, supplemented by proprietary sub-brands such as Sofargen (wound care), Valetonina (sleep aid), and Tokovys (smoking cessation), with go-to-market executed via an enterprise field-sales motion targeting HCPs and a dedicated healthcare-professional portal.

Strategically, Win Medica is a subsidiary of the ELPEN Group, participating in a combined 400+ million euro investment program with sister companies DEMO ABEE and FARAN that is creating over 1,500 direct and indirect high-specialization jobs. The firm has grown to 210-220+ professionals serving approximately 650,000 patients annually across 42+ countries, with a portfolio of 87+ registered products. Its competitive position rests on established Greek regulatory and distribution infrastructure, vertically integrated manufacturing now anchored by the Tripoli plant, and a broad alliance network with 14+ multinational pharmaceutical partners, though no revenue, financial performance, or AI/ML capabilities are publicly disclosed.

Win Medica firmographics

Firmographics
Name
Win Medica
Legal name
WIN MEDICA A.E.
Website
https://winmedica.gr
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
101–250 employees
Short description
Greek pharmaceutical company (founded 2008, Athens) that in-licenses, registers, and commercializes innovative treatments across 11 therapeutic areas for Greek patients and 42+ international markets, supported by a new 500 million-tablet Tripoli manufacturing facility and 14+ multinational pharma partnerships.
Ownership category
akta.pro rank

Where Win Medica is headquartered

Location

Headquarters

HQ city
Athens
HQ country
Greece
HQ region
Europe

Offices2 records

Markets served

Win Medica business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical product sales: Win Medica develops and delivers treatments across specialty medicines, chronic care, and vaccines & consumer health. They in-license, register, and commercialize innovative treatments from global pharmaceutical partners.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Win Medica product offering

Product offering

Core offering

Win Medica is a Greek pharmaceutical company that in-licenses, registers, and commercializes innovative pharmaceutical treatments in partnership with leading global pharmaceutical companies. The company develops, manufactures, and distributes a portfolio of 87+ prescription medicines, OTC products, medical devices, and dietary supplements across 11 therapeutic areas including specialty medicines (oncology, hematology, immunology, urology), chronic care (hypertension, diabetes, cholesterol, obesity), and vaccines/consumer health.

Product overview

Win Medica is a Greek pharmaceutical company (since 2008) specializing in in-licensing, registration, and commercialization of innovative treatments. The company operates a portfolio of 87+ pharmaceutical products including prescription medications, OTC products, medical devices, and dietary supplements. Their therapeutic focus spans four areas: (1) Specialty medicines in oncology, hematology, immunology, and urology; (2) Chronic care including branded generics for hypertension, diabetes, cholesterol and obesity; (3) Vaccines and consumer health; and (4) Advanced manufacturing via their new Tripoli facility with 500 million tablet capacity. Key branded products include Sofargen® (Repair, Spray, Gel) wound care medical devices, SiderAL® iron supplements (Forte, Folico, Sport, Drops), Valetonina® melatonin/valerian sleep aid, UltraMag® Oro magnesium supplement, Vitrex-Easydrip insulin needles, and On Call glucose meters. The company holds strategic partnerships with multinational pharmaceutical companies including Seqirus, Novartis, Accord, Viatris, Servier, and others to distribute their products in the Greek market.

Differentiator

Problem solved

Functional benefit

Brands

  • Sofargen: Wound care product line including Sofargen Repair (water-based dressing with hyaluronic acid and silver sulfadiazine), Sofargen Spray (powder for minor wounds), and Sofargen Gel
  • SiderAL
  • Valetonina
  • UltraMag Oro
  • Tokovys

Products and services

  • Sofargen® Repair Water-based wound dressing containing hyaluronic acid and silver sulfadiazine for topical treatment of skin lesions including abrasions, cuts, wounds, burns, and superficial wounds.
  • Sofargen® Spray Medical device in powder form containing kaolin and silver sulfadiazine for treatment of minor skin wounds including cuts, abrasions, and superficial wounds.
  • Sofargen® Gel Medical device gel with silver sulfadiazine and high water content (>95%) for wound care, maintaining wound moisture and preventing infections.
  • Valetonina® Dietary supplement combining melatonin and valerian with innovative dual-release technology for treatment of insomnia and jet lag.
  • UltraMag® Oro Magnesium supplement utilizing patented sucrosomal technology for enhanced absorption to treat magnesium deficiency symptoms including insomnia, fatigue, muscle cramps, and headaches.
  • Vitrex - Easydrip High-tech pen-type insulin scalpers and needles from Scandinavia, compatible with most insulin devices and pens on the market. Available in 30G, 31G, and 32G sizes.
  • Tokovys® Smoking cessation treatment containing cytisinicline.
  • SiderAL® Sport Iron and vitamin B-complex supplement using sucrosomal technology for athletes and those with increased physical or mental demands.
  • On Call Extra Glucose meter for diabetes monitoring.
  • On Call Vivid Glucose meter for diabetes monitoring.

Quantifiable outcome

  • 500 million tablets per year manufacturing capacity
  • +2 more outcomes

Companies that use Win Medica

Customer profile

Named customers2 records

Segments5 records

Win Medica technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Win Medica partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core.

  • SeqiruscoreStrategic or Co-development PartnerStrategic alliance bringing Seqirus vaccine products to the Greek market, including FLUAD influenza vaccine
  • NovartiscoreStrategic or Co-development PartnerStrategic alliance with Novartis for distribution of pharmaceutical products in Greece
  • AccordcoreStrategic or Co-development PartnerStrategic alliance with Accord for generic pharmaceutical products
  • PharmanutracoreStrategic or Co-development PartnerPartnership with Pharmanutra for consumer health products including UltraMag Oro and SiderAL products
  • AdamedcoreStrategic or Co-development PartnerStrategic alliance with Adamed for pharmaceutical product distribution
  • MabxiencecoreStrategic or Co-development PartnerStrategic partnership with Mabxience for biosimilar and pharmaceutical products
  • ChemocoreStrategic or Co-development PartnerStrategic alliance with Chemo for pharmaceutical product distribution
  • MediscoreStrategic or Co-development PartnerStrategic partnership with Medis for pharmaceutical products
  • SofarcoreStrategic or Co-development PartnerStrategic alliance with Sofar for pharmaceutical product distribution
  • WeldingcoreStrategic or Co-development PartnerStrategic partnership with Welding for pharmaceutical products
  • ViatriscoreStrategic or Co-development PartnerStrategic alliance with Viatris for generic and specialty pharmaceutical products
  • ServiercoreStrategic or Co-development PartnerStrategic partnership with Servier for pharmaceutical product distribution
  • PolpharmacoreStrategic or Co-development PartnerStrategic alliance with Polpharma for generic pharmaceutical products
  • Midas PharmacoreStrategic or Co-development PartnerStrategic partnership with Midas Pharma for pharmaceutical products

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Win Medica competitors and assessment

Company assessment

Broad incumbents

  • Viatris: Global pharmaceutical company formed from Mylan-Pfizer Upjohn, focused on generics and specialty. Strategic partner of Win Medica (supplying generic and specialty products to the Greek market) and a direct competitor in the broader European branded-generics space.
  • Stada Arzneimittel: European-focused generics and specialty pharma leader with consumer health business. Closely comparable business model combining generics, specialty, and consumer health across European markets with similar product breadth.
  • Novartis: Global originator pharmaceutical leader with deep Greek market presence. Strategic distribution partner of Win Medica and a broad incumbent whose therapeutic areas (oncology, immunology, chronic care) overlap with Win Medica's portfolio.

Regional players

  • Polpharma: Polish pharmaceutical manufacturer and one of the largest generic producers in Central Europe. Strategic partner of Win Medica and a comparable regional generic-and-specialty player with cross-border distribution reach.
  • Adamed Pharma: Polish pharmaceutical company with branded generics, specialty, and consumer health operations across Central/Eastern Europe. Strategic partner of Win Medica and comparable in product mix and regional orientation.
  • Krka: Slovenian-headquartered generic pharmaceutical manufacturer with strong presence across Central, Eastern, and Southern Europe. Comparable vertically integrated generics + specialty model serving similar regional markets.

Direct peers

  • FARAN ABEE: Sister company within ELPEN Group focused on pharmaceutical manufacturing and distribution. Co-investor in the €400M+ strategic investment plan with Win Medica, operating in overlapping therapeutic segments.
  • Mabxience: Global biosimilars developer and manufacturer. Strategic partner of Win Medica and a comparable in-licensing/partner-driven player bringing biologic products into regional European markets, with overlapping specialty therapeutic focus.
  • ELPEN Pharmaceutical: Parent company of Win Medica and the largest Greek pharmaceutical manufacturer. Directly comparable vertically integrated model combining manufacturing, R&D, and domestic commercialization of branded generics and specialty products.
  • DEMO ABEE: Sister company under ELPEN Group and one of Greece's largest injectable pharmaceutical manufacturers. Joint strategic investor in the Tripoli facility and directly comparable in product categories (sterile injectables, hospital specialty).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

Win Medica social profiles

Digital presence

Win Medica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Win Medica leadership team

Management profile

Number of profiles

Win Medica funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Win Medica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Win Medica

What does Win Medica do?

Win Medica is a Greek pharmaceutical company that in-licenses, registers, and commercializes innovative pharmaceutical treatments in partnership with leading global pharmaceutical companies. The company develops, manufactures, and distributes a portfolio of 87+ prescription medicines, OTC products, medical devices, and dietary supplements across 11 therapeutic areas including specialty medicines (oncology, hematology, immunology, urology), chronic care (hypertension, diabetes, cholesterol, obesity), and vaccines/consumer health.

Is Win Medica a public or private company?

Win Medica is a private company. It is classified as corporate owned and is currently operating.

When was Win Medica founded?

Win Medica was founded in 2008. It employs 101 to 250 people.

Where is Win Medica based?

Win Medica is headquartered in Athens, Greece, in the Europe region.

How does Win Medica make money?

One revenue line is on record: pharmaceutical product sales.

Who are Win Medica's main competitors?

Broad incumbents on record are Viatris, Stada Arzneimittel and Novartis. Regional players are Polpharma, Adamed Pharma and Krka. Direct peers are FARAN ABEE, Mabxience, ELPEN Pharmaceutical and DEMO ABEE.

Does Win Medica have an API?

No public API is recorded for Win Medica.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals